NHI Expenditure Negotiation Committee suggests abolishing daily drug fees of short forms ( 2010-02-04 )
NHI Expenditure Negotiation Committee suggests abolishing daily drug fees of short forms (2010/02/04)
Reported by Wang Chang-Min from Taipei
The short forms used by primary care clinics to claim drug
THRF requests to disclose NHI secret accounts ( 2010-02-03 )
THRF requests to disclose NHI secret accounts (2010/02/03)
Reported by Wang Chang-Min and Wei Yi-Chia from Taipei
DOH Minister, Yaung Chih-Liang, expressed yesterday that the 2nd Generation NHI and
Premier Wu: 2nd Generation NHI system is now a high priority ( 2010-02-01 )
Premier Wu: 2nd Generation NHI system is now a high priority (2010/02/01)
Reported by Lin Hsiu-Yi
After DOH Minister’s announcement of the adjustment of NHI premium, Premier Wu hit the brake by restating
|
|
IRPAM the Ninth Term Board of Directors and Supervisors Election Results
IRPAM the Ninth Term Board of Directors and Supervisors Election Results
DOH moved to new office
New address of DOH: No. 36, Ta-Cheng St., Taipei
BPA: No. 80, Lin-Shen N. Rd., Taipei
Authorized Distributors' List of IRPMA Member Companies
To urge the customers to purchase products through the authorized distributors, IRPMA announced the authorized distributors' list of IRPMA member companies.
PMS Registry System is now launched
Following the approval of the 2006 IRPMA COP benchmarks on Post-Marketing Study, we are glad to announce the launch of the IRPMA PMS Registry System at IRPMA official website.
In accordance with the IRPMA COP Benchmarks No. 9, all post-marketing studies conducted by IRPMA member companies should be registered on the website.
IRPMA member companies are required to email the PMS information by the attached form sheet to the IRPMA secretariat prior the first patient screening of the PMS, then the secretariat will publicize the information on the registry system.
DOH announcement of the guideline for the test of teh electronic and IR thermometers. ( 2009-02-25 )
公告「臨床電子體溫計」、「紅外線耳溫槍」、「含粉手術用手套」等3項臨床前測試基準草案。
衛署藥字第0980302115號
DOH announcement of the re-evaluation of pergolide products (01/12/2009) ( 2009-01-15 )
公告含pergolide成分藥品之安全再評估結果相關事宜。
|
